Clinical Trial Update: Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty. [NA]

View source ↗

Summary

The clinical trial evaluating All'InCath for peripheral vascular angioplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• All'InCath

Snippet

Sponsor: NexStep Medical | Conditions: Vascular Diseases | NA | Status: WITHDRAWN